Actelion Pharmaceuticals Deutschland GmbH
- Pharmaceutical Sales 2010
-
worldwide: 1.93 billion CHF
- Product Range
- Pulmonary arterial hypertension (PAH), digital ulceration, metabolic disorders (Morbus Gaucher, Niemann Pick Disease Type C)
- Key Research Areas
- The endothelin system, playing a role in the pathophysiology of diseases (oncology, cardiovascular diseases), CNS, storage disorders, sleep disorder, antiinfectiva, respiratory disorders, pulmonal fibrosis, psoriasis, Gaucher Disease Type 1
- R&D Expenditure 2010
-
Worldwide: 484 million CHF
- Employees in the Pharmaceuticals Division 2010
-
Worldwide: 2,400
(All data based on corporate information, as of: 05/2011)
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Unless indicated otherwise, data and keywords refer to the company's human therapeutics sector in Germany and to that of its international Group worldwide.
Suggest page
Print page
Bookmark page